← Eichor
Study identifier: NCT04545606 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Condition: Insomnia Chronic · Autism Spectrum Disorder  ·  Sponsor: University of Missouri-Columbia

PhaseNA
Planned participants180
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersNo

About this study

Children with Autism Spectrum Disorder (ASD) and insomnia, and their parent(s) will undergo 4 sessions of behavioral therapy for sleep problems followed by 4 bimonthly booster sessions. Children and their families will be randomly assigned to one of three conditions: cognitive behavioral therapy (in-person), cognitive behavioral therapy (remote), or behavioral therapy (remote). Arousal will be measured through heart-rate variability. Sleep and secondary outcomes (child daytime behavior, parent sleep) will be collected at baseline (weeks 1-2 before starting the treatment), post-treatment (weeks 6-8 from baseline), 6-month follow-up, and 12-month follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Melanie Stearns, PhD  ·  859-327-7762  ·  mastearns@health.missouri.edu

Sydney Shoemaker, MS  ·  573-882-5113  ·  sds3mk@health.missouri.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Thompson Center for Autism and Neurodevelopmental DisordersColumbia, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04545606